2,138.5
+3.53%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Sysmex
Its shares trade on Tokyo Stock Exchange under the ticker 6869.T. It has been listed since 15 November 1995. In the fiscal year to 31 March 2026, it reported revenue of ¥500.01bn and net income of ¥35.46bn. At that date it held total assets of ¥707.53bn and shareholders' equity of ¥505.00bn.
Sysmex Corp. engages in the healthcare business. The company is headquartered in Kobe, Hyogo-Ken. The firm conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 15 Nov 1995
- Employees
- 8,200
- Website
- sysmex.co.jp ↗
Leadership
Pay as last reported
- Mr. Hisashi IetsuguChairman of the Board, Group Chief Executive Officer, Representative Director, since 1986¥242.0m
- Mr. Kaoru AsanoPresident, Representative Director, since 2009¥221.0m
- Mr. Tomokazu YoshidaManaging Executive Officer, Chief Technology Officer, Director, since 2017
- Mr. Iwane MatsuiSenior Managing Executive Officer, Director, since 2011¥106.0m
- Mr. Kenji TachibanaSenior Managing Executive Officer, Director, since 2011¥121.0m
- Mr. Takashi OnoManaging Executive Officer, Director, since 2019
- Mr. Frank BuescherSenior Executive Officer
- Mr. Kensuke IizukaSenior Executive Officer
- Mr. Mitsuhisa KanagawaSenior Executive Officer
- Mr. Alain BaverelExecutive Officer
- Mr. Andy HayExecutive Officer
- Mr. Naohiko MatsuoExecutive Officer
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 80
- Environment
- 99
- Social
- 99
- Governance
- 41
- Direct emissions (scope 1)
- 13,925 t
- Energy emissions (scope 2)
- 6,706 t
- Value chain emissions (scope 3)
- 564,191 t
- Women in the workforce
- 41.50018%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Sysmex Corp is renowned for its advanced medical technology and laboratory testing equipment. This gives the company a competitive advantage in providing cutting-edge diagnostic solutions to healthcare providers worldwide.
- With a wide distribution network and well-established subsidiaries in numerous countries, Sysmex Corp has a strong international presence. This allows the company to serve a diverse customer base and explore new market opportunities.
- Sysmex Corp invests significantly in research and development, enabling continuous innovation in the medical diagnostics field. This enables them to introduce new products and stay ahead of competitors.
Weaknesses
- Sysmex Corp heavily relies on a few key products, which could pose a risk if there is a decline in demand or potential product obsolescence. Diversification of their product portfolio might mitigate this risk.
- As a healthcare company, Sysmex Corp operates in a highly regulated industry. Changes in regulations or policies can impact their operations, requiring constant adaptation and compliance efforts.
Opportunities
- The increasing healthcare needs of the global population present significant growth opportunities for Sysmex Corp. They can expand their reach and offer innovative solutions to address emerging health challenges.
- Sysmex Corp can venture into untapped markets, especially in emerging economies where demand for advanced medical diagnostics is rising. This would help them diversify their customer base and increase revenue streams.
Threats
- Sysmex Corp faces strong competition from major players in the medical diagnostics industry. Competitors with similar product offerings and well-established market presence can potentially challenge Sysmex Corp's market share.
- Economic downturns or financial instability can affect the healthcare industry, leading to reduced healthcare spending and potential customer budget constraints. Sysmex Corp needs to be prepared to navigate such challenges.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.